本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Pyxis Oncology, Inc.

0.9633
+0.02943.15%
盤後0.9631-0.0002-0.02%19:39 EDT
成交量:28.63萬
成交額:27.20萬
市值:5,933.00萬
市盈率:-0.73
高:0.9734
開:0.9362
低:0.9200
收:0.9339
資料載入中...
2023/06/30

重要事件披露

Form 8-K - Current report
2023/06/30

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/06/29

SEC問詢函

Form CORRESP - Correspondence
2023/06/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/14

重要事件披露

Form 8-K - Current report
2023/06/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/30

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/05/25

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/05/25

重要事件披露

Form 8-K - Current report
2023/05/25

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/05/24

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/05/24

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/05/24

重要事件披露

Form 8-K - Current report
2023/05/24

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/05/11

重要事件披露

8-K - Current report
2023/05/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/10

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/04/04

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/03/28

重要事件披露

8-K - Current report